drugset
drugset / Trial / NCT04703127

Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.

NCT04703127 ↗

Phase 3 Unknown 60 enrolled Sohag University
Non-randomizedParallel-groupSingle-blindTreatment

Summary

Therefore, this study will aim to assess the effectiveness and tolerability of the on-demand use of combined dapoxetine with tadalafil and combined dapoxetine with lidocaine 5% spray in treatment of patients with lifelong premature ejaculation and non-responding to dapoxetine alone.

Timeline

Start
2020-03-30
Primary completion
2021-01-30
Completion
2021-01-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 5 % Topical
Comparator Tadalafil Small molecule 10 mg —
Comparator Dapoxietine Unknown 30 mg —

Indications

premature ejaculation